omniture
logo
Search

/DISREGARD RELEASE: HanAll Biopharma and Daewoong Pharmaceutical/

HanAll Biopharma and Daewoong Pharmaceutical
2022-04-12 15:34 1344

We are advised by HanAll Biopharma and Daewoong Pharmaceutical that journalists and other readers should disregard the news release, "Daewoong Pharmaceutical and HanAll Biopharma Invest in Turn Biotechnologies to Expand Growth Initiative", issued 11-Apr-2022 over PR Newswire.

Source: HanAll Biopharma and Daewoong Pharmaceutical
Related Stocks:
Korea:069620
Media Room more

Daewoong Pharmaceutical Received GMP Certification from Brazilian ANVISA

2023-11-28 08:00
1231

Daewoong Pharmaceutical Initiates Global Export of 'Novel Drug' Launching 'Fexuprazan' in the Philippines

2023-08-16 13:00
2230
Daewoong Pharmaceutical Initiates Global Export of 'Novel Drug' Launching 'Fexuprazan' in the Philippines

Daewoong Pharmaceutical submits a new drug application for Fexuprazan in China challenging the world's largest market for anti-ulcer drugs

2023-07-31 08:00
1742

Daewoong Pharmaceutical has obtained approval for SGLT2i + metformin combination drug Envlomet

2023-07-19 08:52
1919

Daewoong Pharmaceutical Publishes Molecular Mechanism of Bersiporocin as an Antifibrotic in EMBO Molecular Medicine

2023-05-26 06:00
2006

Daewoong Pharmaceutical Presents New Clinical Data of Fexuprazan at Digestive Disease Week 2023

2023-05-19 20:00
1983
Daewoong Pharmaceutical Presents New Clinical Data of Fexuprazan at Digestive Disease Week 2023
Related News

Hanmi Enters into Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate BH3120 in Combination with KEYTRUDA® (pembrolizumab)

2024-04-24 09:27
721

OSR Holdings and SillaJen have entered into a Memorandum of Understanding to collaboratively pursue the development of innovative therapeutics and enter the U.S. market

2024-04-23 18:37
1132

Breakthrough in Lung Cancer Treatment: Dizal to Unveil Groundbreaking Results of Sunvozertinib for Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations at 2024 ASCO Annual Meeting

2024-04-24 22:10
721

Future Health highlights greater access to treatment for Mental Health Month

2024-04-24 22:00
581

CSL Vifor and Travere Therapeutics Announce European Commission approves FILSPARI® (sparsentan) for the treatment of IgA Nephropathy

2024-04-24 15:00
916

Samsung Biologics Reports First Quarter 2024 Financial Results

2024-04-24 14:45
773
collection